ARS Pharmaceuticals, Inc.

Healthcare

NASDAQ:SPRY · NASDAQ Global Market

Market Cap $983.10M Beta 0.83 P/E (TTM) -4.8

$9.65 -3.51%

-$0.35 today

52W Low $6.66High $18.90

Vol 2.27M · Avg 1.67M

EPS (TTM) -$1.99Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-41.76%

Period High

$18.35

Period Low

$6.73

Latest

$9.65

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Nanobiotix S.A.

NASDAQ:NBTX

$1.80B

Tyra Biosciences, Inc.

NASDAQ:TYRA

$1.68B

GH Research PLC

NASDAQ:GHRS

$1.48B

Palvella Therapeutics, Inc.

NASDAQ:PVLA

$1.31B

Savara Inc.

NASDAQ:SVRA

$1.11B

Arbutus Biopharma Corporation

NASDAQ:ABUS

$884.49M

Kura Oncology, Inc.

NASDAQ:KURA

$854.01M

Rezolute, Inc.

NASDAQ:RZLT

$489.16M

ProKidney Corp.

NASDAQ:PROK

$261.47M

LENZ Therapeutics, Inc.

NASDAQ:LENZ

$184.68M

What is the latest SPRY filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does SPRY have?

Intrinsic Alpha currently shows 20 recent filings for SPRY.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.